Related Experiment Videos
The functional domains of coagulation factor VIII:C
The Journal of Biological Chemistry
|September 25, 1986
Summary
Hemophilia A is a bleeding disorder caused by a lack of factor VIII:C. Researchers found that the amino-terminal and carboxyl-terminal domains of factor VIII:C can form an active complex, suggesting a potential therapeutic derivative.
Area of Science:
- Biochemistry
- Genetics
- Hematology
Background:
- Hemophilia A is an X-linked inherited bleeding disorder caused by deficient factor VIII:C.
- Factor VIII:C is crucial for blood clot formation.
Purpose of the Study:
- To identify the minimum functional domains required for factor VIII:C activity.
- To investigate the role of the central domain in factor VIII:C function.
Main Methods:
- Expressed amino-terminal (92-kDa) and carboxyl-terminal (80-kDa) factor VIII:C domains as separate polypeptides in monkey cells.
- Co-expressed the terminal domains to assess clotting activity in factor VIII:C-deficient plasma.
Main Results:
- Neither the 92-kDa nor the 80-kDa domain alone promoted coagulation.
- Co-expression of the 92-kDa and 80-kDa domains resulted in detectable clotting activity.
- The central domain of factor VIII:C is not essential for activity or complex assembly.
Conclusions:
- The amino-terminal and carboxyl-terminal domains of factor VIII:C can form an active or activatable complex independently of the central domain.
- These findings suggest that a truncated factor VIII:C derivative could be a potential therapeutic agent for coagulation disorders.